Clofibrate

Cat. No.: 0225LY-0897

Appearance: Liquid

Purity: ≥99%

Identity: Confirmed by NMR, GC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Clofibrate belongs to the aryloxyisobutyric acid class of derivatives and is utilized for its antihyperlipidemic properties.

Synonym: Clofibrato; Clofibratum; Ethyl clofibrate; 637-07-0; Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate; Ethyl clofibrate; Atromid-S; Atromid; Liprin; Clofibratum; Clofibrato; EPIB; Arterioflexin; Chlorphenisate; Anparton; 2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester; Oxan 600; Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, ethyl ester; Chlorfenisate; Ethyl 2-(p-chlorophenoxy)isobutyrate; Ethyl p-chlorophenoxyisobutyrate; Ethyl para-chlorophenoxyisobutyrate; 2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester; Ethyl 2-(4-chlorophenoxy)-2-methylpropionate

CAS No.: 637-07-0

Compound CID: 2796

Formula: C₁₂H₁₅ClO₃

Formula Weight: 242.7

Specification

Targets&IC50: PPARγ (human): 500 μM (ec50); PPARα (human): 55 μM(ec50); PPARα (murine): 50 μM (ec50); PPARγ (murine): 500 μM (ec50)

Relative Density: 1.14g/mLat 25°C(lit.)

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Clofibrate can be used in cardiovascular studies to investigate the classical activation of PPAR alpha for lowering triglyceride levels.